Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment

Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of a rare genetic disease. The FDA approved Wainua, which has generic name eplontersen, for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. Ionis said Wainua would be available […]

Continue Reading

These are the space stocks to keep an eye on in 2024

From space tourism to rocket launch technologies, these are the space stocks to look out for in 2024. Justus Parmar, CEO of Fortuna Investments, a venture-capital and advisory company currently focused on space investments, sees Virgin Galactic Holdings Inc. SPCE, -10.61% as particularly worthy of attention, pointing to the company’s market cap of $ 1.06 […]

Continue Reading

FedEx stock slumps after delivery giant forecasts sales decline

Shares of FedEx Corp. dropped Wednesday after the package-delivery giant trimmed its full-year sales forecast, amid continued concerns about subdued shipping demand through the peak holiday season. FedEx FDX, -0.68% said it expected a “low-single-digit percentage decline” in sales for its fiscal 2024, compared with a prior forecast for “approximately flat” sales growth. The company […]

Continue Reading